Switch to:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
EV/EBIT
20.52 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its Earnings Before Interest and Taxes (EBIT). As of today, Teva Pharmaceutical Industries Ltd's enterprise value is $70,831 Mil. Teva Pharmaceutical Industries Ltd's earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2015 was $3,452 Mil. Therefore, Teva Pharmaceutical Industries Ltd's EV/EBIT ratio for today is 20.52.

TEVA' s 10-Year EV/EBIT Range
Min: 12   Max: 991
Current: 20.52

12
991

During the past 13 years, the highest EV/EBIT Ratio of Teva Pharmaceutical Industries Ltd was 991.00. The lowest was 12.00. And the median was 20.40.

TEVA's EV/EBITis ranked higher than
58% of the 489 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 26.18 vs. TEVA: 20.52 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Teva Pharmaceutical Industries Ltd's enterprise value for the quarter that ended in Jun. 2015 was $61,732 Mil. Teva Pharmaceutical Industries Ltd's earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2015 was $3,452 Mil. Teva Pharmaceutical Industries Ltd's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2015 was 5.59%.


Definition

Teva Pharmaceutical Industries Ltd's EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Earnings Before Interest and Taxes (EBIT) (TTM)
=70830.530/3452
=20.52

Teva Pharmaceutical Industries Ltd's current Enterprise Value is $70,831 Mil.
Teva Pharmaceutical Industries Ltd's Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2015 was 1112 (Sep. 2014 ) + 929 (Dec. 2014 ) + 749 (Mar. 2015 ) + 662 (Jun. 2015 ) = $3,452 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Teva Pharmaceutical Industries Ltd's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2015 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Jun. 2015 )=EBIT (TTM)/Enterprise Value (Q: Jun. 2015 )
=3452/61732
=5.59 %

Teva Pharmaceutical Industries Ltd's Enterprise Value for the quarter that ended in Jun. 2015 was $61,732 Mil.
Teva Pharmaceutical Industries Ltd's Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2015 was 1112 (Sep. 2014 ) + 929 (Dec. 2014 ) + 749 (Mar. 2015 ) + 662 (Jun. 2015 ) = $3,452 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Earnings Yield (Joel Greenblatt), Earnings Before Interest and Taxes (EBIT)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebit 21.1431.6115.6338.8021.8413.5525.6919.9229.8214.51

Teva Pharmaceutical Industries Ltd Quarterly Data

Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15
ev2ebit 21.0079.6330.6229.8232.0116.8915.4614.5116.2817.88
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK